NCT00311740View on ClinicalTrials.gov

A Study of VAH631 in Patients With Essential Hypertension (Factorial Study)

PHASE3CompletedINTERVENTIONAL
Enrollment

582

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

September 30, 2006

Study Completion Date

September 30, 2006

Conditions
Hypertension
Interventions
DRUG

Valsartan

DRUG

Hydrochlorothiazide

Trial Locations (1)

Unknown

Novartis Pharmaceuticals, Tokyo

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY

NCT00311740 - A Study of VAH631 in Patients With Essential Hypertension (Factorial Study) | Biotech Hunter | Biotech Hunter